Search Results - "Hegarova, M"

Safety and Efficacy of Immunoadsorption in Heart Transplantation Program by Gazdic, T, Malek, I, Pagacova, L, Slavcev, A, Voska, L, Hegarova, M, Hoskova, L, Kubanek, M, Pirk, J

“…Abstract Background Antibody-mediated rejection (AMR) is a serious complication of organ transplantation, and its treatment is complex. The aim of this study…”
Get full text

Safety and Efficacy of Immunoadsorption in Heart Transplantation Program by Gazdic, T, Malek, I, Pagacova, L, Slavcev, A, Hegarova, M, Hoskova, L, Kubanek, M, Pirk, J

Get full text

Left Ventricle Mechanical Circulatory Support Implantation as Successful Bridge to Transplantation for Patients with Cardiac Cachexia by Hegarova, M, Malek, I, Melenovsky, V, Dorazilova, Z, Kettner, J, Maly, J, Netuka, I, Pirk, J

Get full text

Thrombophilias Prospective Detection Tailored Anticoagulation Protocol Without Antiplatelet Therapy in Patients With Axial-Flow Ventricular Assist Device by Netuka, I, Urban, M, Ivak, P, Maly, J, Besik, J, Riha, H, Dorazilova, Z, Hegarova, M, Pirk, J, Szarszoi, O

Get full text

Cardiac Allograft Vasculopathy Assessed By Quantitative Coronary Angiography: A Single Center Prospective Study by Pazdernik, M, Malek, I, Melenovsky, V, Maxian, R, Binova, J, Franekova, J, Jabor, A, Karmazin, V, Hegarova, M, Kautzner, J

Get full text

Comparison of clinical guidelines for the diagnosis and treatment of chronic heart failure of ČKS and ESC 2012 by Spinar, J, Vitovec, J, Hradec, J, Malek, I, Meluzin, J, Spinarova, L, Hosková, L, Hegarova, M, Ludka, O, Taborsky, M

“…Abstract In 2012, the Czech and European clinical guidelines for diagnosis and treatment of heart failure have been issued. The main difference between them is…”
Get full text

Significance of Subtreshold Values of Complement Activation in Myocardium After Cardiac Transplantation by Malek, I, Gazdič, T, Hegarová, M, Voska, L, Pirk, J

Get full text

(1) - A Prospective Randomized Controlled Trial of Direct Oral Anticoagulant Therapy with a Fully Magnetically Levitated LVAD: The DOT-HM3 Study by Netuka, I., Tucanova, Z., Ivak, P., Gregor, S., Kolesar, D.M., Marek, T., Melenovsky, V., Binova, J., Dorazilova, Z., Hegarova, M., Podolec, M., Riha, H., Connors, J., Mehra, M.R.

Get full text

A Pseudotwist Pattern of LVAD Outflow Graft Stenosis - A Cautionary Tale by Tucanova, Z., Pokorny, M., Szarszoi, O., Ivak, P., Hegarova, M., Riha, H., Netuka, I.

“…Left ventricular assist devices (LVADs) play a fundamental role in treating end-stage heart failure. Outflow graft stenosis (OGS) represents a serious…”
Get full text

Systematic Evaluation of HeartMate 3 Inflow Cannula at Transplant and the Association with Reduced Anticoagulation by Tucanova, Z., Ivak, P., Konarik, M., Szarszoi, O., Fabian, O., Melenovsky, V., Hegarova, M., Dorazilova, Z., Netuka, I.

“…Pumps inflow cannula design considerably impacts thrombus formation proclivity that translates to a risk of thrombotic events. Long-term performance of the…”
Get full text

Prognosis Estimation in Heart Transplant Candidates With the Transposition of Great Arteries (TGA) After Mustard or Senning Correction in the Childhood: The Retrospective Analysis by Hegarová, M, Dorazilová, Z, Melenovský, V, Vrbská, J, Malý, J, Netuka, I, Pirk, J, Málek, I

Get full text

576 Left Ventricular Assist Devices for Treatment of Severe Pulmonary Hypertension in Heart Transplant Candidates by Dorazilova, Z, Kettner, J, Netuka, I, Hegarová, M, Málek, I, Pirk, J

Get full text

Czech Society of Cardiology guidelines for the diagnosis and treatment of chronic heart failure 2011 by Špinar, J, Vítovec, J, Hradec, J, Málek, I, Meluzín, J, Špinarová, L, Hošková, L, Hegarová, M, Ludka, O, Táborský, M

“…Abstract Guidelines of Czech Society of Cardiology are released in accordance with ESC guidelines for the diagnosis and treatment of acute and chronic heart…”
Get full text

Erratum to: “Czech Society of Cardiology guidelines for the diagnosis and treatment of chronic heart failure 2011” [Cor et Vasa 54 (2012) e113–e134] by Špinar, J, Vítovec, J, Hradec, J, Málek, I, Meluzín, J, Špinarová, L, Hošková, L, Hegarová, M, Ludka, O, Táborský, M

Get full text

Hepatitis E Virus after Heart Transplantation, Single Center Experience by Hegarová, M., Fraňková, S., Trunečka, P., Málek, I., Melenovský, V.

“…Hepatitis E virus (HEV) infection can cause chronic hepatitis and can lead to liver cirrhosis and liver failure in patients after solid organ transplantation…”
Get full text

(116) The Magentum 2 Study: Long-Term Analysis of Complete Withdrawal of Anticoagulation Therapy with the Heartmate 3 LVAD by Tucanova, Z., Ivak, P., Gregor, S., Hegarová, M., Dorazilova, Z., Marek, T., Melenovsky, V., Riha, H., Crandall, D., Connors, J., Mehra, M., Netuka, I.

“…The hemocompatible HeartMate3 (HM3) LVAD has demonstrated near-elimination of pump thrombosis but bleeding adverse events (AE) persist. We previously…”
Get full text

The value of B-type natriuretic peptide and big endothelin-1 for detection of severe pulmonary hypertension in heart transplant candidates by Kubánek, Miloš, Málek, Ivan, Kautzner, Josef, Hegarová, Markéta, Wiendl, Martin, Lupinek, Petr, Karasová, Ludmila, Lánská, Věra

“…Background: Severe pulmonary hypertension (PH) and increased pulmonary vascular resistance (PVR) are important risk factors that predict early postoperative…”
Get full text

Non-Fontan Adult Congenital Heart Disease Transplantation Survival is Equivalent to Acquired Heart Disease Transplantation Survival by Besik, Josef, MD, Szarszoi, Ondrej, MD, Hegarova, Marketa, MD, Konarik, Miroslav, MD, Smetana, Michal, MD, Netuka, Ivan, MD, Pirk, Jan, MD, Maly, Jiri, MD

“…Background As a result of improved diagnostic methods, medical treatment, surgical correction, and palliation in childhood, there is a growing number of adult…”
Get full text